Controlling hyperlipidemia is an important aspect in the treatment and prevention of coronary artery disease. This article provides the clinician with a general reference for currently used lipid-lowering agents. Lipoproteins present in the plasma are defined and a brief overview of their functions is presented. Normal lipid uptake from the intestine and normal lipid metabolism are discussed to provide a basis for an understanding of the pharmaceutical treatment of hyperlipidemia. Guidelines are reviewed for interpreting lipid profiles according to the National Cholesterol Education Program. An evaluation of the agents currently used to treat hyperlipidemia is included. Lipid-lowering agents cause alterations in liver function; therefore, patients taking these medications are monitored closely. Patient teaching, including adverse effects of the medications, diet therapy and other alterable risk factors, is also reviewed
Skip Nav Destination
Article navigation
1 May 1992
Cardiovascular Pharmacology|
May 01 1992
Lipid-lowering Drugs
Melinda M. Milander, RN, BSN, CCRN;
From Educational Services, Hamburg, New York.
Reprint requests to Melinda M. Milander, RN, BSN, CCRN, Section of Cardiology, 1501 N. Campbell, Health Sciences Center, Tucson, AZ 85724.
Search for other works by this author on:
Merrily Kuhn, RNC, PhD, CCRN
Merrily Kuhn, RNC, PhD, CCRN
From Educational Services, Hamburg, New York.
Search for other works by this author on:
AACN Adv Crit Care (1992) 3 (2): 494–506.
Citation
Melinda M. Milander, Merrily Kuhn; Lipid-lowering Drugs. AACN Adv Crit Care 1 May 1992; 3 (2): 494–506. doi: https://doi.org/10.4037/15597768-1992-2020
Download citation file:
Sign in
Don't already have an account? Register
AACN Account
Sign InSign in via your Institution
Sign in via your InstitutionShort-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
1
Views